Home >  News >  August, 2014

Drug Mix-Up Blinds Patient, Spurs Malpractice Verdict

Cataract patient given methylene blue instead of VisionBlue.

Published: August 22, 2014

A mix-up over sound-alike drugs is at the heart of a $1.5 million jury award earlier this week stemming from a botched cataract procedure that left a patient blind in one eye.

You might say the cataract team at North Carolina Specialty Hospital blue it. Ophthalmologist Timothy Young, MD, PhD, who at the time was practicing with co-defendant North Carolina Eye, Ear, Nose and Throat, in Durham, called for the ophthalmic dye VisionBlue during a cataract removal in 2008, according to news reports. But a nurse instead retrieved methylene blue, a compound sometimes used in endoscopic polypectomies and one that's toxic to eyes.

Both the nurse and a surgical technician testified that they announced what the drug was before it was given to Dr. Young, but he testified that he didn't hear them.

A second procedure to repair the severe damage caused by the mix-up failed, as did a full corneal transplant.

Calls for comment by Outpatient Surgery Magazine to Dr. Young, who now practices in Texas, and to North Carolina Eye, Ear, Nose and Throat, were not returned.

Jim Burger


Also in the News...

Philly Eye Facility Adds 4 Inpatient Beds, Insists It's Now a Hospital
Doc No Longer Facing Drug-Theft Charges, But Hospital That Accused Him in Hot Water
A Colonoscope You Won't Have to Reprocess
Simethicone in Scopes Could Pose Infection Risk
Clinic Where Joan Rivers Was Stricken Sues Its Insurance Carrier
How Well Do PONV Predicting Systems Work?
Is Medicare Ready to Reimburse Outpatient Knee Replacement?

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Bacterial Outbreak Mars Free Cataract Surgery Program for Seniors

Seniors who received free cataract surgery also received vision-threatening infections.

Surgical Tech Believed Cell Phone Was Implanted Inside His Brain

Health department suspends his license amid reports of other strange conduct.

FDA Reclassifies Vaginal Mesh as High-Risk Device and Orders Manufacturers to Address Safety Concerns

The move is the latest effort to improve the safety of transvaginal pelvic organ prolapse procedures.